Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
First trench is for 15 million, right? They may not even tap second trench!
He's actually referring to a tranche, but perhaps he should just ditch the whole idea.
Long ago, when my wife was in business school, she read me part of a paper that argued, in essence, that the majority is right the vast majority of the time.
Reminds me of this blog from last year: at what point does mere puffery and hyperbole actually become harmful to consumers?
Striking contrasts of hype versus rational reporting in leukemia story
http://www.healthnewsreview.org/2011/08/striking-contrasts-of-hype-versus-rational-reporting-in-leukemia-story/
maby I would....I play with money I can effort to loose
Perhaps play just a tad more with your spelling.
Re ARQL: Great add, I was too slow on the trigger.
I took a moderate-size position this past hour, average about $5.40. It hasn't been in that range since June, so I'm satisfied.
Best of luck.
How can you calculate a 60% drop in PPS after R/S when the company is making money now?
I've been looking at ARQL for some time but haven't pulled the trigger.
I've been following today's thread with great interest. It looks like it might be a good buying opportunity anywhere in the low $5's.
Any input is greatly appreciated.
Erlotinib has been suspected of causing interstitial lung disease (ILD), especially in the Asian population.
As long as we are talking about hypotheticals, what if after failing to produce significant ORR, Bavi converted the immune system of the patients from that of H. Sapiens into that of Kryptonians? Since on earth we are in the presence of a yellow sun, the Kryptonian immune system would eradicate the H. sapien cancer cells and produce a 100% cure rate. Would the FDA approve that?
must have core position in tack for rocket ride.
An arraigned trade is a trade who's done a very bad thing and now finds himself in court!
This PPHM poster thinks that shorting a stock is illegal and will personally complain to the SEC: #msg-78951587
When they see that it's from SpongeBob SquarePants, I'm sure they'll get right on it.
sure would be nice if whatever impetus you are illiuding to could happen sooner than later
Illiuding: Referring to something that makes you sick.
When asked what he meant by a miracle:
"Oh, anything with a probability of less than 20%." — Enrico Fermi
What a great blast-from-the-past post; isn't 20/20 hindsight wonderful?
Re PCYC, not one of Wallstarb's best calls:
I'd be amazed if anyone bought $24m worth of this crummy company. Seems like they are suffering from a pretty big bout of hubris.
They are pretty much out of cash - just let them die and by the IP out of bankruptcy.
Why I like biotech as a sector...
Shamed to confess I decided PCYC was fully priced at 31.
I don't understand.
Didn't you just post this on another board: #msg-78868860
From an amusing blog called,The Ethics of Disagreement: Dealing with the Unreasonable:
http://everyday-ethics.org/2009/04/the-ethics-of-disagreement-dealing-with-the-unreasonable/
"The unreasonable are people who are not capable of understanding what a rational argument is, yet insist on replying to whatever challenge you raise against them. For example, if you say “the position advocated by person X, which you are endorsing, claims Y, which is not supported by the fact of Z,” the unreasonable will respond by saying “X is much smarter than you, and you just don’t understand Y.” Notice that this reply is nothing more than an ad hominem attack, and that it utterly fails to account for the conflict between claim Y and the fact of Z. Further, the unreasonable will feel genuinely vindicated by this non-response.
This is exceedingly frustrating for reasonable people, because we tend to think that reasons make a difference, and that when someone challenges your view with a legitimate argument, you ought to respond with an argument of your own. The self-righteousness of the unreasonable, coupled with the insulting and derogatory nature of their typical responses makes it tempting to set your own standard of civility aside, and explain to them specifically why they are not only wrong, but also mildly retarded."
Oh yes, sad but true my friend.
"The best argument against democracy is a five-minute conversation with the average voter." -Winston Churchill
Hang in there.
The economy, the stock market, housing, banking, health care, education, the everyday fabric of our lives, the personal and intellectual quality of the President himself, all better than during the Bush disaster.
Uh-oh, help, emergency, we're in deep trouble: call in the Mormons!
Excellent.
It was the "by the end of August" or "by the end of September" question that was troubling me.
Thanks for making the call.
Perhaps another addition to the Common Biotech-Newbie Mistakes list:
If all the members of a stock-specific message board speak to each other like they’re simple, uneducated, guileless salt-of-the-earth good ole’ boys, using as many homespun and folksy regionalisms as possible (even to the point of writing bad imitation-Faulkner hillbilly dialogue), then they must be telling the truth, the stock must be legitimate, and all critics must be lying, manipulating, city-slicker Yankees.
Excellent, thanks for making that call. You'll see, he's a nice guy, very helpful.
As is customary, the institutional shareholders—the real power-base—will follow the BOD’s suggestions, not to mention that they have a full understanding of all the dynamics involved. A reverse split is all but inevitable if the target is not reached by then. That "target date" is my question.
Yes, they still might RS, but totally IMHO I would guess not. Campanelli, speaking for the company, has been very passionate in stating that they do not want that, that they want a rise in the PPS using gradual, organic growth.
If a RS did happen, no big deal, you and I and other informed investors understand that it might be for the best.
Let me know what you find out, and thanks again.
Ranch & Ecomike: Of course, the funds and experienced retail investors understand the dynamics of reverse splits.
I hate to post inaccurate information and I’m usually quite careful not to, but I might have made a small but important error regarding the requirements to regain compliance.
In June I spoke to Brad Howes (a VP at FBC and the Investor Relations Officer) and I thought that we were in agreement as to the compliance specifics, but perhaps there was a misunderstanding.
I have carefully reread Section 804.00, Procedure for Delisting, in the NYSE Listed Company Manual:
“The company can regain compliance at any time during the six-month cure period [this was extended through the annual meeting, hence the delay in having that meeting] if on the last trading day of any calendar month during the cure period the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.”
http://nysemanual.nyse.com/LCMTools/PlatformViewer.asp?selectednode=chp_1_9_4&manual=%2Flcm%2Fsections%2Flcm-sections%2F
My original understanding was that the $1 average had to be maintained over any random 30 trading-day period ending in a day with a closing share price of at least $1. Upon closer reading I see that the end day must be the last trading day of any calendar month during the cure period.
To me it means that since the Annual Meeting is on September 24, then Friday, August 31, is the deadline.
Brad is a very friendly and professional person, but I feel that I've used up my alloted time. Could one of you two give him a call (248-312-2000) and see if I'm reading the regulations correctly, or if they do indeed have until the end of September?
Does it need to hit the 30 day closing average of one dollar at the close of just one day?
There are 24 trading days left until the Sept. 24 Annual Meeting (Sept. 3 is Labor Day).
Remembering that to cure the deficiency they need a $1+ closing price average for a consecutive 30-trading-day period (not for 30 consecutive trading days) there's still a slim chance, but they need to hit the afterburners now.
Sorry, sure this has been asked many times before:
iHub procedure for a threatening or obscene PM?
I think we'd all love for this to happen. Can't happen when PPHM longs continue to overrun this board with their posts.
Fannie and Freddie are talking crap again on the banks
When is this crapola ever going to stop?
I will have too talk to my tax people, I'm payed $136825 on last years gains......kinda high for not knowing what I'm doing oldberk.
"It is as useless to argue with those who have renounced the use of reason as to administer medication to the dead." -Thomas Jefferson
Delete
"The City of Dallas is experiencing a widespread outbreak of mosquito-borne West Nile virus and has caused and appears likely to continue to cause widespread and severe illness and loss of life," Mayor Michael Rawlings said in the proclamation of emergency that takes effect Wednesday"
Before investing real money in the stock market, I always advise a person to learn the basics. There are many good books and websites available, including one (I think) on iHub.
You also might want to try this book: http://www.amazon.com/Stock-Investing-Dummies-Paul-Mladjenovic/dp/0764554115
Fair enough, let's hope so.
Again, to summarize, all IMHO:
1. I'm certainly hoping and even expecting the price to rise in the coming weeks.
2. I'm skeptical--with so little time left--if the RS can be avoided.
3. If there is a RS, rather than a doom & gloom scenario there's an excellent chance that things will improve.
Best of luck.
I realize that this is a controversial and perhaps even heretical remark to make (especially on iHub) but I'm not a big believer in charts.
Fundamentally FBC is recovering and sooner or later it will be over $2, but not in time to avoid a RS.
I'm too lazy to look at the historical prices for the last few weeks and determine exactly what future closing prices would be necessary to establish a $1 average 30-day period, but it could be done.
Although I'd greatly prefer that outcome, and have been honestly expecting and predicting it for many months, I'm now reluctantly accepting that it is very unlikely. Most likely we will see the 1-for-10 reverse split.
The nature of these splits, the reasons why they're done, and the specifics of the companies who do them are completely understood by the street, but often very poorly understood by retail buyers.
Hence the comment from an earlier poster who wondered why someone would buy the stock at ten times the current price!
What I'm now hoping for is a CRBC-type situation where the PPS begins a healthy climb after the split.
Exactly.
It's not a particularly hard mathematical concept to grasp (try fifth grade math!) but I basically gave up trying to explain it to some of the knuckleheads on the Yahoo board.
For example, 15 daily closes at $.90 and 15 daily closes at $1.10 would give a $1 average for 30 trading days. The higher up it goes moving forward, the farther back you can go to include days with lower- priced closings in your 30 consecutive-day grouping.
Your suggested scenario of daily closings in the $1.50 range would be great, but it really wouldn't even have to go that high.
Potentially for a shorter time than that.
Remember, it needs to have a $1 average closing price for 30 consecutive trading days. If it can get to $1.05 - $1.10 for a few weeks, we can average in these days in the .90's.